Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Title Grant Type Focus Area Country Application Due Date Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Quality Improvement in Pediatric Endocrinology fieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan Topical Hemostasis in Minimally Invasive SurgeryRelease Date:Education Hospital USA Advances in Immuno-Oncology Therapy in Urothelial CancerRelease Date:Education Oncology Japan Integration of Biomarker Testing into Treatment Planning for Metastatic Colorectal CancerQuality Improvement Oncology USA IBD Fellow Training in USRelease Date:Education Inflammation & Immunology USA Imaging Diagnostics for Differentiating Cardiac AmyloidosisRelease Date:Education Rare Disease Japan Telemedicine Initiatives for Patients with Suspected Cardiomyopathy of Unknown CauseRelease Date:Education Rare Disease Japan Improving Treatment Environment for Chronic Myeloid Leukemia (CML)Release Date:Education Oncology Japan Atrial Fibrillation and Venous Thromboembolism (excluding United States)Education Internal Medicine All Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and CaregiversRelease Date:Research Inflammation & Immunology France, Germany, Italy, Japan, Spain, United Kingdom China Breast Cancer Landscape – Educational Needs AssessmentRelease Date:Education Oncology China